Inhaled corticosteroids: managing side effects Inhaled corticosteroids are commonly prescribed but need careful management to minimise the risk of side effects.…
Mistakes made by patients using medical devices points to need for better trainingA research team sought to identify the factors associated with incorrect use of metered-dose inhalers and epinephrine autoinjectors.…
Asthma: long-term management Asthma management is based on a stepwise approach that should see medicines added or stopped based on patient symptoms.…
Asthma: pathophysiology, causes and diagnosis Despite asthma affecting more than 5.4 million people in the UK, there is no gold standard test and diagnosis is based on signs and symptoms.…
Combination inhaler Anoro Ellipta launched for COPD Anoro Ellipta, a novel inhaler containing a long-acting muscarinic receptor antagonist and a selective long-acting beta-2 adrenergic receptor agonist, may find a limited place in therapy.…
Paradoxical bronchoconstriction occurs in 5% of COPD patients treated with beta-2-agonists African–American patients with COPD are more likely to be affected by therapy-induced bronchoconstriction, study suggests.…
Montelukast shows promise for treating children with 5/5 ALOX5 genetic variant, study suggests Subgroup analysis indicated that montelukast outperformed placebo in children with the 5/5 ALOX5 variant.…
Inhaled steroids suppress growth in children, conclude Cochrane reviewers Reviews of data about the effects on growth of corticosteroid inhalers in asthmatic children have reinforced guidance that the lowest effective dose should be given.…
